Ruhsen Öcal
Başkent University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ruhsen Öcal.
Neurological Sciences | 2014
Bilal Aytaç; Ozlem Coskun; Bulent Alioglu; Zahide Esra Durak; Süleyman Büber; Esra Tapci; Ruhsen Öcal; Levent E. Inan; I. Durak; Tahir Kurtuluş Yoldaş
Migraine patients have an increased risk to develop deep white matter hyperintensities (WMH) than the general population. Oxidative stress is believed to play a role in the pathogenesis of migraine. The present study was undertaken to assess oxidant/antioxidant balance of migraineurs with and without WMH. We hypothesized that increased oxidative stress and decreased antioxidant response may play a role in the pathophysiology of WMH in migraineurs. The study included 32 patients in the migraine group and 17 age- and sex-matched healthy subjects without headache in the control group. The migraine group comprised 18 with WMH and 14 without WMH. We evaluated oxidative status with malondialdehyde (MDA) and to determine the activities of antioxidant enzymes: superoxide dismutase, glutathione peroxidase and catalase (CAT) in serum of migraineurs and controls. Comparison of the patient and control groups for oxidative parameters revealed significantly lower level of CAT and higher level of MDA in the patient group. Two-way comparison for CAT and MDA of the migraine with and without WMH and the controls revealed that CAT serum level significantly decreased in migraine patients with WMH than migraine patients without WMH and controls. In this preliminary study, we demonstrated that the levels of CAT were decreased in migraine patients with WMH compared to patients without WMH and controls. These findings suggest that decreased antioxidant response may play a role in the pathophysiology of WMH in migraineurs. Besides, our results encourage the new treatment and follow-up options based on antioxidant systems.
European Neurology | 2015
Eda Derle; Ruhsen Öcal; Seda Kibaroglu; Ufuk Can
A 69-year-old woman presented with sudden onset of diplopia. In neurologic examination left medial rectus palsy without abduction nystagmus was detected. Brain magnetic resonance imaging revealed acute ischemic lesion in mesencephalon on diffusion-weighted images. Sponteneous resolution was observed after 1 month. Medial rectus palsy is a rare presention of acute ischemic stroke and early neuroimaging is important to establish such lesions.
The journal of the Turkish Society of Algology | 2014
Ozlem Coskun; Serap Ucler; Ruhsen Öcal; Levent E. Inan
Hemicrania continua (HC) is a rare primary headache disorder. It presents some autonomic features (including conjunctival injection, ptosis, eyelid edema, lacrimation, nasal congestion, and rhinorrhea). Response to indomethacin treatment is the mandatory criteria for the diagnosis of HC. However, previously reported literature indicates that there are some reported cases that did not respond to indomethacin. In this case report, we present a patient who had indomethacin resistance with an associated pregabalin response. Pregabalin may be an effective treatment for hemicrania continua in some patients with indomethacin resistance.
Blood Coagulation & Fibrinolysis | 2016
Eda Derle; Ruhsen Öcal; Seda Kibaroglu; Ceyda Çelikkol; Nilufer Bayraktar; Hasibe Verdi; Belgin F. Ataç; Ufuk Can
Aspirin resistance occurs in 5–45% of high-risk patients, with various mechanisms proposed for its development. This study aimed to determine the relationships among aspirin resistance, aspirin dosage, type of aspirin and glycoprotein IIIa P1A1/A2 polymorphism in patients with vascular risk factors. Two hundred and eight (75 symptomatic, 133 asymptomatic) patients with vascular risk factors who were using aspirin for primary or secondary prevention were prospectively included. The symptomatic group was further classified into two groups according to aspirin use at the time of stroke. Aspirin resistance was measured by the PFA-100 system (collagen/epinephrine cartridge) and glycoprotein IIIa P1A1/A2 polymorphism was determined by PCR. The overall prevalence of aspirin resistance was 32.2%. The mean age of patients with aspirin resistance was significantly higher than that in those who did not have resistance (P = 0.009). The prevalence of aspirin resistance was similar for the symptomatic and asymptomatic under aspirin therapy groups. The resistance rate was found to be highest with 100 mg enteric-coated preparation use (39.3%). Increasing the aspirin dosage and/or shifting to uncoated preparations caused a change in aspirin sensitivity of 36–60%. Repeated measurements showed development of aspirin resistance in 14% of patients who were sensitive to aspirin in previous measurements. Glycoprotein IIIaP1A1/A2 polymorphism, aspirin resistance and development of atherothrombotic stroke were not significantly related. The effect of aspirin can change by time, dosage and type of preparation used. There are no relationships among glycoprotein IIIa P1A1/A2 polymorphism, aspirin resistance and development of atherothrombotic stroke.
Cephalalgia | 2018
Ilkin Iyigundogdu; Eda Derle; Leyla Asena; Feride Kural; Seda Kibaroglu; Ruhsen Öcal; Imren Akkoyun; Ufuk Can
Aim To compare the relationship between white matter hyperintensities (WMH) on brain magnetic resonance imaging and retinal nerve fiber layer (RNFL), choroid, and ganglion cell layer (GCL) thicknesses in migraine patients and healthy subjects. We also assessed the role of cerebral hypoperfusion in the formation of these WMH lesions. Methods We enrolled 35 migraine patients without WMH, 37 migraine patients with WMH, and 37 healthy control subjects examined in the Neurology outpatient clinic of our tertiary center from May to December 2015. RFNL, choroid, and GCL thicknesses were measured by optic coherence tomography. Results There were no differences in the RFNL, choroid, or GCL thicknesses between migraine patients with and without WMH (p > 0.05). Choroid layer thicknesses were significantly lower in migraine patients compared to control subjects (p < 0.05), while there were no differences in RFNL and GCL thicknesses (p > 0.05). Conclusions The ‘only cerebral hypoperfusion’ theory was insufficient to explain the pathophysiology of WMH lesions in migraine patients. In addition, the thinning of the choroid thicknesses in migraine patients suggests a potential causative role for cerebral hypoperfusion and decreased perfusion pressure of the choroid layer.
Turkish Journal of Cerebrovascular Diseases | 2017
Zeynep Özözen Ayas; Ruhsen Öcal; Ayhan Bölük
At the present time the incidence of illicit drug use increases worldwide among young adults. Abuse of these substances is a rare cause of stroke in young adults. Cocaine, heroin, cannabis, and amphetamines use increase the risk of stroke. Cannabis sativa induce main effects by delta-9-hydrocannabinol. The main mechanism of marijuana-related stroke in young patients is vasospazm. The other possible mechanisms are systemic hypotension, impaired cerebral autoregulation, alteration of cerebral blood flow, cardioembolism due to atrial fibrillation. In this article a 25-year-old young male patient with paresia and paresthesia of right side who had chronic abuse of marijuana is reported. Clinicians must be alert about marijuana can be seriously harmful to cerebrovascular system in chronic use.
Ideggyogyaszati Szemle-clinical Neuroscience | 2017
Zeynep Özözen Ayas; Ruhsen Öcal; Aslı Aksoy Gündoğdu
Posterior reversible encephalopathy syndrome (PRES) is a disorder which is diagnosed with its characteristic clinical and radiological findings, typically resolves with treatment. The prevalence of PRES in systemic lupus erythematosus (SLE) patients is not exactly known. A systemic disorder frequently appears as a presenting symptom in SLE. However, in rare cases, the disease starts with a neurological manifestation. Here we report a 35-year-old woman presenting with a headache and blurred vision. She had neurologic symptoms and cerebral lesions on magnetic resonance imaging (MRI) suggesting PRES. The patient was diagnosed with SLE during the etiological investigation of PRES. In this article, we aimed to emphasize that PRES as an initial presentation of SLE.
Experimental and Clinical Transplantation | 2017
Ruhsen Öcal; Ceyda Tanoglu; Seda Kibaroglu; Eda Derle; Ufuk Can; Mahir Kirnap; Gokhan Moray; Mehmet Haberal
OBJECTIVES Neurologic complications are common after kidney and liver transplant. Neurologic complications affect mortality and morbidity in transplant recipients, and neuropathic pain is an important symptom affecting a patients quality of life. The aim of the present study was to provide readers with our experience regarding causes and treatment of neuropathic pain in patients undergoing kidney and liver transplant at our transplantation center. MATERIALS AND METHODS The medical data of 553 kidney transplant recipients and 258 liver transplant recipients who received transplant procedures at the Baskent University Transplantation Center between 2008 and May 2016 were retrospectively reviewed. Fifty-one patients who were examined by an expert neurologist and diagnosed with neuropathic pain on the basis of clinical, neurologic examination, and laboratory findings were included for analyses. RESULTS Among 811 transplant recipients, 51 patients (6.2%) were diagnosed with neuropathic pain. Of these, 22 were female and 38 were male patients, and 42 were kidney transplant recipients and 9 were liver transplant recipients. Causes of neuropathic pain included uremia, diabetes mellitus, ischemic peripheral arterial disease, inflammatory neuropathy, vasculitis, discopathy, postherpetic neuralgia, carpal tunnel syndrome, and multiple myeloma. Patients with symptoms too mild to affect daily life activities were treated conservatively. Plasmapheresis, gabapentin, pregabalin, alpha-lipoic acid, and duloxetine were administered as treatment modalities and medications. CONCLUSIONS Neuropathic pain was lower in our transplant recipients than in the general population. Treatment medications were effective for transplant recipients at lower doses for the management of neuropathic pain impairing quality of life than doses for the general population.
Turkish Journal of Medical Sciences | 2016
Hülya Eser; Yasemin Ünal; Gülnihal Kutlu; Ruhsen Öcal; Levent E. Inan
BACKGROUND/AIM This study aimed to define the frequency of a primitive reflex, the buccopalpebral reflex (BPR), and its association with the clinical situation in patients with Parkinson disease. MATERIALS AND METHODS Between May 2010 and May 2011, 222 patients, 115 with Parkinson disease and 107 patients without any sign of neurodegenerative disease, were included in the study. All included patients were examined for BPR and snout reflex and were also evaluated with the Mini Mental State Examination. All patients with Parkinson disease were classified with the Unified Parkinsons Disease Rating Scale (UPDRS) and the Hoehn and Yahr Score to determine their clinical severity. RESULTS Sixteen patients with Parkinson disease (13.9%) had a BPR (+) and 4 patients in the control group (3.7%) (P < 0.001). The UPDRS score, UPDRS daily life activities score, and UPDRS motor system score were all higher in the group with BPR (+). All patients with a BPR also had a positive snout reflex. CONCLUSION BPR is more frequent in patients with Parkinson disease than in patients without a neurodegenerative disease.
Acta Neurologica Belgica | 2015
Eda Derle; Seda Kibaroglu; Pınar Cınar; Ruhsen Öcal; Ufuk Can
A 61-year-old woman admitted to our hospital with acute onset of confusion, speech, and gait disturbance. She had previous history of diabetes and end-stage renal disease, and she was on oral antidiabetic medication and regular hemodialysis for 4 months. Neurologic examination demonstrated dysarthria, postural instability, and bradykinesia. Laboratory examination showed elevated blood urea nitrogen (55 mg/dl) and creatinine (5.8 mg/dl), metabolic acidosis (pH: 7.09, HCO3: 5.6 mmol/l), and normal glucose level. Brain computerized tomography performed at the first day of admission revealed bilateral hypodensities on basal ganglia (Fig. 1). She received treatment for metabolic imbalance, and hemodialysis was continued three times a week, without any additional treatment for brain lesions. Brain magnetic resonance imaging (MRI) was performed on a 1.5 T unit (Siemens Symphony, Erlangen, Germany) including T1-weighted, T2-weighted, fluidattenuated inversion recovery (FLAIR), and diffusionweighted images (DWI) at the forth day of admission. On brain MRI, T2-weighted and FLAIR images showed bilateral and symmetric basal ganglia hyperintensities and also increased signal on DWI with increased apparent diffusion coefficient values, which were compatible with vasogenic edema (Fig. 2) [1]. Metabolic acidosis gradually improved with treatment, and she was discharged after 2 weeks. Follow-up evaluation performed at first month of initial presentation, showed only mild bradykinesia on neurologic examination, and brain MRI revealed remarkable resolution of the previously described lesions (Fig. 2).